drugset / Trial / NCT06238388
Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis Patients
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, nonrandomized, and open design study to investigate metabolism and excretion of HSK21542 in maintenance hemodialysis patients.
Timeline
- Start
- 2023-10-10
- Primary completion
- 2023-11-21
- Completion
- 2024-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK21542 | Peptide | 0.8 ug/kg | Intravenous |